Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 97 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,372 | -31.0% | 3,371 | -14.0% | 0.00% | – |
| Q2 2023 | $26,624 | +20.0% | 3,921 | -11.5% | 0.00% | – |
| Q1 2023 | $22,194 | -70.6% | 4,430 | -71.4% | 0.00% | – |
| Q4 2022 | $75,517 | -66.1% | 15,475 | 0.0% | 0.00% | – |
| Q3 2022 | $223,000 | -31.4% | 15,475 | -27.9% | 0.00% | – |
| Q2 2022 | $325,000 | +173.1% | 21,468 | +114.7% | 0.00% | – |
| Q1 2022 | $119,000 | -26.5% | 9,999 | 0.0% | 0.00% | – |
| Q4 2021 | $162,000 | -42.6% | 9,999 | +0.9% | 0.00% | – |
| Q3 2021 | $282,000 | +73.0% | 9,914 | +105.2% | 0.00% | – |
| Q2 2021 | $163,000 | +19.0% | 4,831 | +6.7% | 0.00% | – |
| Q1 2021 | $137,000 | -35.4% | 4,528 | +5.3% | 0.00% | – |
| Q4 2020 | $212,000 | +27.7% | 4,301 | -0.9% | 0.00% | – |
| Q3 2020 | $166,000 | -32.0% | 4,342 | -23.3% | 0.00% | – |
| Q2 2020 | $244,000 | +106.8% | 5,659 | +25.1% | 0.00% | – |
| Q1 2020 | $118,000 | -32.6% | 4,522 | -19.2% | 0.00% | – |
| Q4 2019 | $175,000 | +98.9% | 5,599 | +65.1% | 0.00% | – |
| Q3 2019 | $88,000 | +12.8% | 3,392 | 0.0% | 0.00% | – |
| Q2 2019 | $78,000 | +178.6% | 3,392 | +215.8% | 0.00% | – |
| Q1 2019 | $28,000 | +27.3% | 1,074 | 0.0% | 0.00% | – |
| Q4 2018 | $22,000 | – | 1,074 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 216,916 | $6,191,000 | 3.86% |
| Sofinnova Investments, Inc. | 2,194,278 | $62,625,000 | 3.71% |
| MPM BioImpact LLC | 452,970 | $12,928,000 | 2.00% |
| Soleus Capital Management, L.P. | 265,700 | $7,583,000 | 1.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 452,110 | $12,903,000 | 1.17% |
| ORACLE INVESTMENT MANAGEMENT INC | 315,642 | $9,008,000 | 1.12% |
| First Light Asset Management, LLC | 577,663 | $16,487,000 | 1.09% |
| Lombard Odier Asset Management (Switzerland) SA | 352,839 | $10,070,000 | 0.62% |
| Cormorant Asset Management, LP | 500,000 | $14,270,000 | 0.58% |
| Artal Group S.A. | 400,000 | $11,416,000 | 0.26% |